NCT00000393View on ClinicalTrials.gov

A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 31, 1988

Primary Completion Date

January 31, 1990

Conditions

HIV InfectionsCognition Disorders

Interventions

DRUG

Peptide T

Trial Locations (1)

90033

Los Angeles County - USC Med Ctr, Los Angeles

All Listed Sponsors

lead

National Institute of Mental Health (NIMH)

NIH